Gs Investments, Inc. Bristol Myers Squibb CO Transaction History

Gs Investments, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$65.71 - $74.53 $10,185 - $11,552	-155 Reduced 0.43%	35,525 $2.46 Million
Q4 2022 Feb 07, 2023	BUY	$68.48 - $81.09 $8,902 - $10,541	130 Added 0.37%	35,680 $2.57 Million
Q3 2022 Nov 10, 2022	SELL	$0.13 - $76.84 $24 - $14,445	-188 Reduced 0.53%	35,550 $2.53 Million
Q2 2022 Aug 03, 2022	SELL	$72.62 - $79.98 $78,502 - $86,458	-1,081 Reduced 2.94%	35,738 $2.62 Million
Q1 2022 Apr 26, 2022	BUY	$61.48 - $73.72 $122 - $147	2 Added 0.01%	36,819 $2.8 Million
Q4 2021 Feb 09, 2022	SELL	$53.63 - $62.52 $45,049 - $52,516	-840 Reduced 2.23%	36,817 $2.3 Million
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $2.23 Million - $2.61 Million	37,657 New	37,657 $2.23 Million
Q1 2021 May 07, 2021	SELL	$59.34 - $66.74 $1.57 Million - $1.76 Million	-26,444 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$57.74 - $65.43 $1.53 Million - $1.73 Million	26,444 New	26,444 $1.64 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Gs Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Gs Investments, Inc. with notifications on news.